Published • loading... • Updated
ABL Diagnostics Appointed by the Commercial Court of Évry to Take over the Activities of TEXCELL
Summary by Business Wire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Paris – Compartment B – ISIN: FR001400AHX6), a company specializing in molecular diagnostic solutions, healthcare software, and clinical sample management, announces that it has been appointed by the Commercial Court of Évry to acquire the assets and operations of TEXCELL. This decision is part of the industrial plan presented by ABL Diagnostics aimed at ensuring busines…
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
